NovaScan
3 known investors
NovaScan develops a platform technology combining AI and spectral bioimpedance for oncology applications, with multiple diagnostic and intraoperative products built on a shared hardware and software foundation currently in clinical trials.
Investors · 3
In the news
Grey Matters Health secures Florida radioactive materials license for flagship neuroimaging clinic | CSE:GREY, OTCQB:AGNPDproactiveinvestors.com · Aug 2026
Grey Matters Health secures imaging partnership and regulatory approval for Florida NovaScan clinic | CSE:GREY, OTCQB:AGNPDproactiveinvestors.com · Aug 2026
Grey Matters Health taps ProScan for brain PET scan interpretation in Florida | CSE:GREY, OTCQB:AGNPDproactiveinvestors.com · Aug 2026Frequently asked questions
- What does NovaScan do?
- NovaScan develops a platform technology combining AI and spectral bioimpedance for oncology applications, with multiple diagnostic and intraoperative products built on a shared hardware and software foundation currently in clinical trials.
- Who are NovaScan's investors?
- NovaScan's investors include Dipalo Ventures, Green Park & Golf Ventures, Portal Innovations.